Tecnologia Etica e Sostenibile: Mobility, Smartphone, Gadget, Tablet, App, AI

Cosmetic Lasers Market: Trends, Growth & Future Outlook (2018–2032)

The cosmetic lasers market is undergoing a transformative shift, fueled by advancements in aesthetic technologies, rising consumer demand for non-invasive cosmetic procedures, and the integration of AI-driven devices. This booming sector, which blends science, technology, and beauty, is gaining traction globally among both healthcare professionals and end users seeking safe and effective cosmetic enhancements.

According to Fortune Business Insights, the global aesthetic/cosmetic lasers market size, valued at USD 1.78 billion in 2018, is projected to soar to USD 15.44 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 16.7% during the forecast period from 2018 to 2032.

Key Market Highlights

Exponential Market Growth The cosmetic laser market has demonstrated robust growth in recent years due to increased consumer awareness and acceptance of aesthetic treatments. The market’s impressive CAGR of 16.7% underlines strong future potential, fueled by innovative treatments such as skin resurfacing, body contouring, acne/scar reduction, and laser hair removal. Expanding applications in dermatology clinics, medical spas, and hospitals further contribute to rising product demand. North America Leads the Market North America emerged as the dominant regional market in 2018, accounting for a 37.08% market share. High disposable income, growing cosmetic consciousness, and widespread adoption of advanced laser equipment contribute to this leadership. The presence of major aesthetic device manufacturers and a strong network of dermatologists and cosmetic surgeons supports continued dominance. Rising Popularity of Non-Invasive Procedures Consumer preference is shifting toward minimally-invasive and non-invasive aesthetic treatments, which offer faster results, minimal downtime, and reduced risk. Laser technologies now support a range of skin concerns—such as pigmentation, wrinkles, vascular lesions, and unwanted hair—with increasing precision and safety. Technological Advancements Driving Innovation AI-integrated systems, real-time skin diagnostics, and multi-platform laser systems are revolutionizing how cosmetic lasers are used. New devices offer customizable treatment parameters, skin-type specific settings, and improved cooling technologies that enhance patient comfort and satisfaction. These innovations are fostering rapid adoption across clinics and medispas. Surge in Aesthetic Clinics and Medical Tourism The global increase in the number of aesthetic clinics and certified dermatology centers has made cosmetic laser procedures more accessible. In parallel, medical tourism is booming, especially in countries like South Korea, Thailand, Turkey, and India, which offer high-quality cosmetic services at competitive prices. Key Players in the Cosmetic Lasers Market

The global market is highly competitive, with both established players and innovative startups contributing to rapid innovation and market expansion. Leading companies include:

Alma Lasers (Sisram Medical Ltd.) Known for a wide range of aesthetic platforms including hair removal, skin rejuvenation, and body contouring. Cutera, Inc. Specializes in advanced laser and energy-based devices with a strong presence in the dermatology sector. Candela Corporation Offers robust product lines such as Vbeam and GentleMax Pro for hair removal and vascular treatments. Lumenis Ltd. A pioneer in minimally-invasive aesthetic technologies; now a part of Boston Scientific. Cynosure (A division of Hologic, Inc.) Offers diverse solutions including PicoSure and Icon for pigmentation, tattoo removal, and skin resurfacing. Fotona Renowned for dual-wavelength laser systems used in dermatology, aesthetics, and gynecology. Sciton, Inc. Known for customizable platforms like BBL and HALO that address various skin concerns. Quanta System Provides advanced laser solutions for medical and aesthetic use, with a strong presence in Europe. Sharplight Technologies Offers a range of IPL and laser-based solutions for professional skincare. Solta Medical (A division of Bausch Health Companies Inc.) Known for innovative systems like Thermage and Fraxel. These companies continue to invest in R&D, strategic acquisitions, and global expansion to strengthen their market positions.

Market Segmentation Overview

By Product Type:

Ablative Lasers: Effective for resurfacing and tightening. Non-Ablative Lasers: Preferred for minimal downtime treatments. Laser-Based Devices: Multi-purpose platforms for diverse skin conditions. By Application:

Hair Removal Skin Rejuvenation Tattoo Removal Scar & Acne Treatment Vascular Lesion Treatment By End-User:

Hospitals Aesthetic Clinics Home-Use Devices (Emerging Segment) Regional Outlook

Region

Market Insights

North America

Leading market, high adoption, strong regulatory support.

Europe

Rapid uptake in Germany, UK, France; focus on anti-aging.

Asia-Pacific

Fastest-growing region; cosmetic tourism and rising disposable incomes.

Latin America

Growing awareness and demand in Brazil, Mexico.

Middle East & Africa

Emerging markets with increased aesthetic awareness.

Challenges and Opportunities

Challenges:

High cost of advanced laser devices. Risk of side effects without professional handling. Regulatory variations across countries. Opportunities:

Rising male consumer base in aesthetics. Growth in at-home laser devices. Integration of AI and machine learning for treatment personalization. Browse Detailed Summary of Research Report with TOC: https://www.fortunebusinessinsights.com/industry-reports/aesthetic-cosmetic-lasers-market-101530

Conclusion

The cosmetic lasers market is on a high-growth trajectory, poised to reshape the future of aesthetic medicine. With advancements in technology, growing consumer demand for youthful appearance, and a strong pipeline of innovative devices, the market offers lucrative opportunities for manufacturers, healthcare providers, and investors alike.

As the industry moves toward personalized, AI-driven, and minimally invasive solutions, staying ahead of trends and understanding market dynamics will be crucial for success in the coming decade.

Browse Related Reports

Cystic Fibrosis Market Size, Global Industry Growth, Forecast 2032

Diabetic Ulcer Treatment Market Size, Strategies and Research Forecast 2032

Artificial Tears Market Industry Growth and Forecast to 2032

Glaucoma Therapeutics Market Outlook, Analysis, Research, Review 2032

Contraceptives Market Size, Industry Growth and Forecast to 2032

Anti-Fungal Drugs Market Discovers the Opportunities, Management to 2032

US Gynecology Robotic Surgery Market Global Key Vendors and Analysis Report 2032

Pain Management Devices Market Overview: Trends, Growth & Forecast (2018–2032)

AI-Generated Overview

The global pain management devices market is witnessing significant growth, driven by rising incidences of chronic pain, increasing geriatric population, and a shift toward non-opioid treatment solutions. Technological innovations and growing awareness regarding pain management therapies have further accelerated market demand. This article provides a comprehensive analysis of the market size, regional dominance, key drivers, major players, and future prospects ideal for healthcare professionals, investors, and industry stakeholders.

Market Size and Growth Forecast

The global pain management devices market size was valued at USD 3,922.9 million in 2018 and is projected to reach USD 14,123.9 million by 2032, exhibiting a compound annual growth rate (CAGR) of 9.6% during the forecast period (2018–2032). Growth is fueled by

Increasing prevalence of chronic diseases (e.g., arthritis, cancer). Rising preference for minimally invasive pain therapies. Growing demand for non-opioid solutions. Advancements in medical technologies. Dominance of North America

North America held the largest market share of 77.29% in 2018, making it the undisputed leader in the pain management devices industry. Key reasons include

Advanced healthcare infrastructure and facilities. High patient awareness and treatment adoption. Presence of leading device manufacturers. Government support for non-opioid treatment approaches. The United States, in particular, is a significant contributor due to its high healthcare spending and favorable regulatory environment.

Key Market Drivers

Rising Geriatric Population An aging population with a higher incidence of chronic diseases is increasing demand for effective pain treatment solutions. Shift from Opioids to Device-Based Therapies Due to concerns over opioid addiction and side effects, both physicians and patients are leaning toward safer alternatives like neurostimulation and infusion pumps. Technological Advancements Modern devices offer improved precision, efficacy, and patient comfort, driving adoption rates. Better Awareness and Early Diagnosis Growing awareness among patients and clinicians is leading to early intervention, thus fueling device demand. Segmentation Insights

The market is segmented by device type and application:

By Device Type: Neurostimulation Devices Ablation Devices Analgesic Infusion Pumps Others By Application: Neuropathic Pain Cancer Pain Musculoskeletal Pain Migraine Facial & Dental Pain Others Neurostimulation devices dominate the segment due to their versatility and long-term relief outcomes.

Key Players in the Pain Management Devices Market

Several global and regional players are actively shaping the pain management devices landscape through innovation, strategic partnerships, and geographic expansion. Key companies include

Medtronic plc – A global leader in neuromodulation and implantable pain relief devices. Boston Scientific Corporation – Known for its Spinal Cord Stimulation (SCS) systems. Abbott Laboratories – Offers advanced neurostimulation devices and has expanded post-acquisition of St. Jude Medical. Smiths Medical – Specializes in infusion therapy and portable pain management solutions. B. Braun Melsungen AG – A strong presence in analgesic infusion and patient-controlled pain therapy devices. Stryker Corporation – Active in radiofrequency ablation and minimally invasive treatment options. Nevro Corp. – Innovator in high-frequency spinal cord stimulation technologies. These companies are heavily investing in R&D to create next-generation devices that offer better pain relief, portability, and user control.

Challenges and Restraints

Despite rapid growth, the market faces challenges:

High costs of devices and treatments. Limited reimbursement in some developing regions. Need for skilled professionals for device implantation and usage. Efforts to overcome these hurdles through innovation and healthcare reform are expected to create new opportunities.

Future Outlook

The pain management devices market is poised for continued expansion through 2032. Emerging economies, increasing R&D investments, and growing patient acceptance of device-based pain relief methods are expected to create vast opportunities for both established and new entrants.

📑 Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/industry-reports/pain-management-devices-market-101069

Conclusion

The pain management devices market is evolving rapidly, offering promising alternatives to traditional pain therapies. With strong market momentum, innovative technology, and increasing awareness of pain-related health issues, the sector is set to grow robustly in the coming years. Stakeholders focusing on quality, affordability, and accessibility are likely to drive the next phase of market transformation.

More Trending Reports:

Hair Transplant Market Innovations, Challenges, and Opportunities 2032

Non-Hodgkin Lymphoma Treatment Market Technological Innovations, Growth, Strategy Profiling 2032

Multiple Myeloma Market Advancements and Opportunities To 2032

E-prescribing Market Emerging Technologies and Opportunities 2032

Neonatal Intensive Care Market Comprehensive Analysis, Forecast to 2032

Skin Cancer Treatment Market | Explore A New Era of Growth 2032

Anti-Inflammatory Drugs Market Growth Prospects, New Developments Forecast To 2032

Molecular Diagnostics Market Overview (2025–2032)

The global molecular diagnostics market is projected to reach USD 21.21 billion by 2032, growing at a robust compound annual growth rate (CAGR) of 4.2% during the forecast period (2025-2032). This rapid expansion is primarily fueled by advancements in precision medicine, growing investment in genomics research, increased healthcare spending across emerging economies, and the rising prevalence of infectious diseases and cancer.

As technology continues to evolve and healthcare systems around the world become more proactive and personalized, molecular diagnostics is emerging as a vital component in early detection, targeted therapy, and effective disease management.

Key Drivers and Market Trends

Increased Focus on Precision Medicine and Genomics Precision medicine is transforming the way healthcare is delivered by tailoring treatments to individual genetic profiles. Governments worldwide are increasingly funding genomic research and personalized medicine initiatives to improve patient outcomes. This trend is significantly boosting demand for molecular diagnostic tools, which are essential for detecting specific genetic mutations and biomarkers that guide personalized treatment decisions.

For example, the U.S. National Institutes of Health (NIH) and various European Union programs have significantly increased funding in this area, enhancing the clinical utility and adoption of molecular tests.

Rising Healthcare Expenditure in Asia Pacific The Asia Pacific region is experiencing a healthcare revolution, with countries like China, India, Japan, and South Korea significantly ramping up their healthcare budgets. This increased expenditure is enabling the development of sophisticated medical infrastructure and diagnostic laboratories, which are essential for the widespread adoption of molecular diagnostics.

Moreover, growing awareness about preventive healthcare and increasing incidences of chronic and infectious diseases are further accelerating the need for advanced diagnostic solutions across the region.

Infectious Disease Diagnostics The infectious disease diagnostics segment remains a dominant force within the molecular diagnostics market. The emergence of pandemics like COVID-19 has underscored the importance of rapid and accurate testing methods. Innovations in PCR (polymerase chain reaction) and isothermal amplification technologies have enabled faster diagnosis and timely intervention.

Advancements in point-of-care (PoC) testing, which provide results in minutes rather than hours, are particularly valuable in outbreak scenarios, making them a crucial area of ongoing research and development.

Oncology Molecular Diagnostics With cancer rates climbing globally, oncology diagnostics has become a critical segment in the molecular diagnostics market. These diagnostics help in early detection, prognosis, and monitoring of treatment effectiveness by identifying specific cancer-related mutations and markers.

Technologies like next-generation sequencing (NGS), liquid biopsy, and companion diagnostics are being widely used to personalize cancer treatment, particularly in conditions like breast, lung, and colorectal cancer.

Technological Advancements in Portability and Turnaround Time One of the most transformative trends in the market is the development of portable, user-friendly, and faster diagnostic devices. These innovations are making molecular diagnostics accessible even in remote and under-resourced healthcare settings.

Miniaturized instruments and lab-on-a-chip technologies are enabling rapid sample processing and reducing dependency on central laboratories, thus enhancing the reach of diagnostic services.

Rising Demand for Point-of-Care (PoC) Diagnostics Point-of-care molecular testing is witnessing surging demand due to its speed, convenience, and mobility. From home-based COVID-19 test kits to mobile TB testing platforms, the trend is shifting diagnostics closer to the patient.

Healthcare providers and patients alike are seeking solutions that reduce time-to-diagnosis, particularly for infectious diseases and chronic conditions. This shift is contributing heavily to the overall growth of the molecular diagnostics market.

Regional Market Trends

North America

North America continues to dominate the global molecular diagnostics market due to:

Advanced healthcare infrastructure High awareness and adoption of precision medicine Presence of key industry players Large patient population and favorable reimbursement policies According to Fortune Business Insights, the U.S. is a leader in genomics and diagnostics innovation, creating a mature and well-regulated environment for molecular diagnostics.

Asia Pacific

Asia Pacific is expected to register the highest CAGR during the forecast period. This growth is fueled by:

Expanding healthcare infrastructure Government initiatives in digital health and diagnostics Rising disposable income and insurance coverage Increasing prevalence of infectious diseases and chronic conditions Countries like India and China are emerging as global hubs for medical tourism and molecular diagnostic research, which will further bolster regional growth.

Key Players in the Molecular Diagnostics Market

Several major companies are shaping the future of molecular diagnostics through innovation, strategic partnerships, and global expansion. Key players include:

Abbott Laboratories Danaher Corporation bioMérieux SA F. Hoffmann-La Roche Ltd Bio-Rad Laboratories, Inc. Agilent Technologies, Inc. Becton, Dickinson and Company Hologic, Inc. (Gen-Probe) Illumina, Inc. Grifols S.A. Qiagen Siemens Healthineers AG Sysmex Corporation These companies are investing heavily in R&D, clinical trials, and geographic expansion to strengthen their market presence and cater to the growing demand for molecular diagnostic solutions.

📑 Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/industry-reports/molecular-diagnostics-market-100086

Conclusion

The molecular diagnostics market is undergoing a significant transformation, driven by technological innovation, healthcare reform, and a growing emphasis on precision medicine. With the market projected to surpass from USD 15.78 billion in 2025 to USD 21.21 billion by 2032, stakeholder including healthcare providers, investors, and governments are recognizing its strategic importance in enhancing patient outcomes and disease management.

As healthcare becomes more personalized, accessible, and data-driven, molecular diagnostics will continue to play a pivotal role in shaping the future of medicine.

More Trending Topics:

X-Ray Flat Panel Detectors Market Size, Technology, Devices, Challenges 2032

Cardiac Rhythm Management Devices Market Innovations, Challenges, and Opportunities 2032

Germany Home Healthcare Market Technological Innovations, Growth, Strategy Profiling 2032

Prothrombin Complex Concentrate Market Advancements and Opportunities To 2032

Pain Management Devices Market Emerging Technologies and Opportunities 2032

Aesthetic Lasers Market Comprehensive Analysis, Forecast to 2032

US Secondary Hyperparathyroidism Treatment Market | Explore A New Era of Growth 2032

Grazie di cuore a tutte e tutti per essere venuti ieri al Politecnico con Richard Stallman: eravamo oltre 300 persone!
@rms :stallman: è rimasto davvero colpito dall’accoglienza, dalla partecipazione e anche dall’ottimo cibo durante i suoi giorni milanesi.

un grande grazie a @gualdo e a @poul_polimi per la logistica e la copertura delle spese, a @iusondemand e @lealternative per il supporto economico.

A breve le foto mie e del team su @fedimedia!

@tecnologia

#richardstallman #Stallman

Pensiamo ad un magazzino pieno di pacchi, e poniamo il problema di identificare facilmente ogni singolo oggetto con le proprie caratteristiche in base a ciò che ogni oggetto è. RFID rappresenta la tecnologia utile per l’identificazione in radiofrequenza, e di fatto si basa sull’applicazione di determinati tag (piccoli hardware applicabili molto facilmente e altrettanto leggeri) ad oggetti, cose o animali, ovvero trasponder (XPDR), cioè piccoli dispositivi in grado di rispondere in automatico a determinate frequenze.

Mercato degli inalatori intelligenti: tendenze globali, dimensioni, quota e previsioni (2025-2032)

🌐 Panoramica del mercato

Il mercato degli inalatori intelligenti è destinato a una crescita esponenziale, trainato dall'aumento dei disturbi respiratori, dai progressi nella salute digitale e dalla domanda di trattamenti personalizzati. Gli inalatori intelligenti, dotati di sensori e tecnologia Bluetooth, aiutano i pazienti a monitorare il dosaggio, l'aderenza terapeutica e l'efficacia del trattamento in tempo reale. Questi dispositivi sono sempre più integrati con le app sanitarie mobili, migliorando sia i risultati clinici per i pazienti che il monitoraggio da parte dei medici. Con l'evoluzione dei sistemi sanitari verso la gestione remota dei pazienti, gli inalatori intelligenti stanno diventando un pilastro fondamentale nella gestione delle cure respiratorie.

📊 Dimensioni e previsioni del mercato (2025-2032)

Il mercato globale degli inalatori intelligenti è stato valutato a 157,2 milioni di dollari nel 2024 e si prevede che raggiungerà i 222 milioni di dollari nel 2025. Nel periodo di previsione, si prevede che il mercato raggiungerà i 2.608,3 milioni di dollari entro il 2032 , con un tasso di crescita annuo composto (CAGR) del 68,12% . Questa straordinaria traiettoria di crescita è alimentata dalla crescente prevalenza di asma e BPCO, dai progressi tecnologici e dalla crescente consapevolezza in merito all'aderenza al trattamento.

📌 Cifre chiave delle previsioni:

2024 : 157,2 milioni di dollari 2025 : 222,0 milioni di USD 2032 : 2.608,3 milioni di dollari Tasso di crescita annuo composto (2025-2032) : 68,12% 🌍 Approfondimenti regionali: il Nord America è leader di mercato

Nel 2024, il Nord America ha dominato il mercato globale degli inalatori intelligenti, con una quota di mercato del 68,32% . Tra i fattori che contribuiscono a questa posizione dominante figurano:

Elevata prevalenza di malattie respiratorie come l'asma e la BPCO Infrastruttura sanitaria avanzata Maggiore adozione delle tecnologie sanitarie digitali Forte presenza di attori chiave del mercato Politiche di rimborso favorevoli e iniziative governative Anche altre regioni, come l'Europa e l'Asia-Pacifico, stanno registrando una crescita promettente grazie alla crescente consapevolezza in materia di assistenza sanitaria, al sostegno governativo e ai crescenti investimenti nella telemedicina e nella sanità connessa.

🏥 Fattori di mercato

Aumento della prevalenza dei disturbi respiratori L'asma e la broncopneumopatia cronica ostruttiva (BPCO) sono in aumento in tutto il mondo e richiedono soluzioni terapeutiche più intelligenti. Progressi tecnologici L'integrazione con app mobili, intelligenza artificiale e piattaforme basate su cloud consente il monitoraggio dei dati in tempo reale e un migliore coinvolgimento dei pazienti. Crescente attenzione all'aderenza terapeutica del paziente Gli inalatori intelligenti aiutano a garantire che i pazienti seguano i trattamenti prescritti, una sfida importante nella gestione delle malattie croniche. Supporto governativo e normativo Aumento dell'approvazione dei dispositivi medici intelligenti da parte delle autorità sanitarie come la FDA e l'Agenzia europea per i medicinali. Monitoraggio remoto dei pazienti Nel periodo post-pandemia si è assistito a un forte spostamento verso soluzioni di assistenza sanitaria a distanza, alimentando ulteriormente la domanda di inalatori connessi. 🧬 Sviluppi recenti (2023–2025)

GSK e Propeller Health hanno ampliato la loro collaborazione, integrando sensori negli inalatori Ellipta per il monitoraggio in tempo reale. AstraZeneca ha lanciato un programma di monitoraggio degli inalatori basato sull'intelligenza artificiale per ridurre i ricoveri ospedalieri tra i pazienti affetti da BPCO. Teva Pharmaceuticals ha potenziato il suo ProAir Digihaler con analisi Bluetooth e AI per supportare la terapia digitale. Novartis ha investito nella startup di inalatori connessi Cohero Health , con l'obiettivo di rivoluzionare il monitoraggio della terapia respiratoria. 3M Drug Delivery Systems ha avviato sperimentazioni cliniche per inalatori intelligenti di nuova generazione compatibili con più farmaci. 🏢 I principali attori chiave del mercato degli inalatori intelligenti (2025)

Teva Pharmaceuticals Industries Ltd. GlaxoSmithKline plc (GSK) AstraZeneca plc Novartis AG Salute dell'elica (ResMed) Cohero Health Adherium Limited Sistemi di somministrazione di farmaci 3M Viatris Inc. Boehringer Ingelheim International GmbH Queste aziende stanno investendo molto in ricerca e sviluppo, partnership e integrazione digitale per rafforzare la propria posizione nel mercato globale.

🔮 Prospettive future

Il mercato degli inalatori intelligenti sta attraversando un momento cruciale. Con l'integrazione di intelligenza artificiale, cloud computing e mobile health, questi dispositivi si stanno trasformando da semplici strumenti per la somministrazione di farmaci a piattaforme complete di gestione sanitaria. Con la continua evoluzione della telemedicina e la crescente digitalizzazione dell'assistenza sanitaria, l'adozione di inalatori intelligenti diventerà una prassi comune sia nelle economie sviluppate che in quelle emergenti.

📑 Esplora il rapporto di ricerca completo con approfondimenti dettagliati e indice: https://www.fortunebusinessinsights.com/smart-inhalers-market-102705

📝 Conclusion Il mercato degli inalatori intelligenti sta attraversando una rapida trasformazione, alimentata dall'innovazione, dall'aumento delle patologie respiratorie croniche e dalla necessità di strumenti di coinvolgimento dei pazienti più intelligenti. Con un CAGR previsto del 68,12% dal 2025 al 2032 e una significativa crescita in regioni come il Nord America , gli inalatori intelligenti sono destinati a ridefinire il nostro approccio alla cura delle vie respiratorie.

Queste cuffie open-ear si distinguono immediatamente dalle tradizionali cuffie, per il loro design a clip, una soluzione originale che permette di indossarle comodamente agganciandole al padiglione auricolare, lasciando il condotto uditivo completamente libero.

Chatbot e documenti

https://prealpinux.com/2025/05/18/chatbot-e-documenti.html

@tecnologia

L'IA ti fa risparmiare tempo

:diggita: @tecnologia

cit marketoonist.com

#AI #IA #iIntelligenzaArtificiale

Tra le novità più interessanti del momento c’è il ventilatore portatile Diveblues N607D, un dispositivo piccolo e compatto, ma sorprendentemente potente che promette di offrirti una vera boccata d’aria fresca ovunque ti trovi.

Con l’aumento delle temperature, i ventilatori portatili ricaricabili stanno diventando sempre più popolari: leggeri, maneggevoli e facili da usare in ogni situazione, sono perfetti per chi è spesso in movimento, lavora in ambienti caldi o semplicemente vuole un po' di sollievo immediato durante la giornata.

Le nuove ROSESELSA EARFREE I5 TWS arrivano sul mercato con una scheda tecnica niente male: cancellazione attiva del rumore (ANC), supporto al codec LDAC, certificazione IPX5, connettività Bluetooth 5.3 il tutto racchiuso in un ottimo design.

Monopolio pubblicità, Google condannata -

Colpevole di aver abusato della sua posizione dominante nel mercato della pubblicità on line. Una seconda sconfitta schiacciante per il gigante tecnologico Usa già condannato per pratiche anticoncorrenziali nella ricerca online

#google #posizionedominante #pubblicitàonline
#praticheanticoncorrenziali

@tecnologia
@news

Negli Stati Uniti si sta pensando di progettare veicoli elettrici generati dall’intelligenza artificiale, il nuovo database della MIT (Ministero infrastrutture dei Trasporti) ha stabilito...